| Financial Year |
March 31 2023 |
| Monetary Funds |
336,631,351.49 |
| Held-for-trading Financial Assets |
181,523,701.37 |
| Notes Receivable |
34,952,957.15 |
| Accounts Receivable |
509,648,190.03 |
| Advances to Suppliers |
4,498,010.06 |
| Other Receivables |
9,431,506.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
119,513,621.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,854,272.28 |
| Total Current Assets |
1,251,821,206.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
121,764,756.44 |
| Under-construction Projects |
6,611,890.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,600,982.09 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,192,178.33 |
| Deferred Income Tax Assets |
18,109,141.24 |
| Other Non-Current Assets |
133,236,250.01 |
| Sub-Total of Non-Current Assets |
288,994,477.35 |
| Total Assets |
1,540,815,683.91 |
| Short-Term Loans |
50,000,000.00 |
| Trading Financial liabilities |
114,121.92 |
| Notes Payable |
-- |
| Accounts Payable |
120,764,824.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,692,733.16 |
| Taxes Payable |
12,594,791.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
473,394.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,756,048.48 |
| Other Current Liabilities |
26,924,179.37 |
| Sub-Total of Current Liabilities |
249,361,629.38 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,026,050.91 |
| Total Liabilities |
253,387,680.29 |
| Paid-In Capital(Or Share Stock) |
176,320,000.00 |
| Capital Surplus |
467,856,827.95 |
| Surplus Reserve |
79,377,508.93 |
| LESS:Treasury Stock |
35,994,181.36 |
| Undistributed Profits |
599,844,464.78 |
| Minority Stockholder's Interest |
524,627.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,286,903,376.01 |
| Owner's Equity（Stockholder's Equity） |
1,287,428,003.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,540,815,683.91 |
